Ifp Advisors, Inc Liminal Bio Sciences Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.32 - $0.5 $40 - $63	-126 Reduced 96.18%	5 $1,000
Q2 2022 Sep 06, 2022	BUY	$0.44 - $0.97 $57 - $127	131 New	131 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.44 - $0.97 $57 - $127	-131 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.82 - $1.13 $107 - $148	131 New	131 $0

234

Ticker LMNL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,042,600
Description
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.